Skip to main content
Equibles

Lion Point Capital, LP

Position in ARDX — Ardelyx, Inc.

CIK 1643354 NEW YORK, NY
Back to ARDX Full portfolio

Position in ARDX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$656,115
-$114,498 QoQ
Shares Held
128,650
0.0% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
3.14%
of 13F equity value
Holder Rank
#85
of 250 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Lion Point Capital, LP holds $18,132,915 across 30 Biotechnology names. ARDX ranks #12 (3.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CUE
Cue Biopharma, Inc.
 52,928 $1,670,407
2 PRAX
Praxis Precision Medicines, Inc.
 4,450 $1,489,815
3 MLTX
MoonLake Immunotherapeutics
 67,500 $1,314,225
4 FENC
Fennec Pharmaceuticals Inc.
 112,434 $1,208,665
5 RPRX
Royalty Pharma plc
 21,400 $1,199,898
6 MIST
Milestone Pharmaceuticals Inc.
 820,000 $1,098,800
7 BNTC
Benitec Biopharma Inc.
 62,000 $829,560
8 SNDX
Syndax Pharmaceuticals Inc
 36,000 $786,960

All Filings in ARDX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $656,115 128,650
2026-03-31 $770,613 128,650
2025-12-31 $750,029 128,650
2025-09-30 $896,752 162,750
2025-06-30 $1,314,768 335,400
2025-03-31 $1,646,814 335,400
2024-12-31 $1,700,478 335,400
2024-09-30 $2,549,300 370,000
2024-06-30 $6,347,902 856,667
2024-03-31 $7,640,669 1,046,667
2023-12-31 $7,140,335 1,151,667
2023-09-30 $4,800,801 1,176,667
2023-06-30 $5,175,401 1,526,667
2023-03-31 $9,755,634 2,036,667
2022-12-31 $5,372,250 1,885,000
2022-09-30 $654,500 550,000